Associated Papers
Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.
Cross WCH et al.
Cancer Discovery, 2026
41563072 (PubMed )
Supplement: cd-24-0813_supplementary_table_7_suppst7.xlsx › C274
The impact of genetic immune disorders on infections including COVID-19, inflammatory bowel disease and cancer.
Xiang C et al.
Nature Immunology, 2025
The JAK/STAT conundrum with mutational heterogeneity, immune defects, and the emergence of targeted therapies.
Demirkaya DB et al.
Expert Review of Clinical Immunology, 2025
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders.
Djidjik R et al.
Frontiers in Immunology, 2025
Infections in Inborn Errors of STATs.
Wang C et al.
Pathogens (basel, Switzerland), 2024
Type I interferon regulation by USP18 is a key vulnerability in cancer.
Jové V et al.
Iscience, 2024
Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2.
Zhu G et al.
Journal of Clinical Immunology, 2023
The link between rheumatic disorders and inborn errors of immunity.
Sogkas G et al.
Ebiomedicine, 2023
Break down the barriers of auto-inflammation: How to deal with a monogenic auto-inflammatory disease and immuno-haematological features in 2022?
Vergneault H et al.
Immunology, 2023
Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy.
Duncan CJA et al.
Journal of Clinical Immunology, 2021
Rare genetic variants in systemic autoimmunity.
Jiang SH et al.
Immunology and Cell Biology, 2020
Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy.
Gruber C et al.
The Journal of Experimental Medicine, 2020
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2.
Duncan CJA et al.
Science Immunology, 2019
Select a paper to view details